Gastrointestinal side effects of anti-obesity medications May 13, 2024 Source: Bartelt, et al Epic Research Network May 1, 2024 LINK A few recent publications give us some additional data about expected side effects from the GLP-1 anti-obesity medications
[13] The current NICE obesity guideline sets out a structured approach involving lifestyle interventions as a first-line measure, licensed pharmacotherapy where clinically appropriate, and bariatric surgery for eligible individuals with severe obesity
Luthione se utiliza en tratamientos de mesoterapia
Zheng et al., Tumor-Induced CD11b + Gr-1 + myeloid cells suppress T cell sensitization in Tumor-Draining Lymph Nodes1
Weight loss medications work by suppressing your appetite, curbing cravings, boosting your metabolism, or preventing your body from absorbing some of the fat you eat
Glucagon-like peptide-1 receptor agonists: new evidence of kidney and cardiovascular protection from the FLOW and SELECT trials